华东医药：2025年第一季度报告（英文版）.PDF

1、First Quarterly Report 2025 of Huadong Medicine Co.,Ltd.1 Stock code:000963 Stock abbreviation:Huadong Medicine Announcement No.:2025-036 Huadong Medicine Co.,Ltd.First Quarterly Report 2025 The Company and all members of the Board of Directors hereby guarantee that the information presented in this

2、 report is authentic,accurate,complete,and free of any false records,misleading statements or material omissions.Important Declaration:1.The Board of Directors,Board of Supervisors,directors,supervisors and senior management of Huadong Medicine Co.,Ltd.(hereinafter referred to as the“Company”)hereby

3、 guarantee that the information presented in this report is authentic,accurate,complete,and free of any false records,misleading statements or material omissions,and shall undertake individual and joint legal liabilities.2.The Companys legal representative,the officer in charge of accounting,and the

4、 head of accounting department(accounting manager)hereby declare that the financial information in this quarterly report is authentic,accurate,and complete.3.Has the First Quarterly Report been audited?Yes No According to“Stock Listing Rules of the Shenzhen Stock Exchange”,if listed companies have b

5、oth Chinese and other language version of public notice,they should ensure the content of both versions are the same.In the case of discrepancy,the original version in Chinese shall prevail.First Quarterly Report 2025 of Huadong Medicine Co.,Ltd.2 I.Key Financial Data(I)Key accounting data and finan

6、cial indicators Whether the Company needs to perform a retroactive adjustment or restatement of previous accounting data Yes No Current reporting period Same period last year Change of the current reporting period over the same period last year(%)Operating revenue(yuan)10,735,787,899.82 10,410,809,1